Singleplex IHC: Immunohistochemistry Analytical Validation (MDACC)
BRD ID: 3165
Tier: SOP
Source: CIMAC-CIDC Network
Number of times downloaded: 488
Description
This assay analytical validation and performance report describes the methods used to validate an automated singleplex immunohistochemical (IHC) staining procedure for the Bond Max instrument, which utilizes small reagent volumes (≥150 µl/slide), to assess CD3, CD4, CD45RO, CD57 (Leu-7), CD68, CD8, Foxp3, Granzyme B, PD-1, PD-L1 immunostaining in formalin-fixed, paraffin-embedded (FFPE) tumor and normal adjacent lung tissue, lymphocytes, and macrophages. The document also presents data that supports the reported accuracy, precision, analytical sensitivity and specificity, and reportable range for each antigen. It is used by the Cancer Immune Monitoring and Analysis Center (CIMAC) at MD Anderson Cancer Center (MDACC). It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).
Biospecimens
TissuePlacenta
CellWhite Cells
TissueLung
TissueTonsil
CellLung
Diagnoses
NeoplasticCarcinoma
Normal
NeoplasticNormal Adjacent
Topics
Platform-specific Methodology